Our regular monthly trawl for new publications from HEDS in collaboration with colleagues in ScHARR and further afield never fails to discover fresh research. Many of these are currently in press and you can find much of our work in its open access form via our institutional repository. Tuck in here.
© Elsevier |
Chambers D, Preston L, Topakas A, de Saille S, Salway S, Booth A, Dawson J, Wilsdon J. Review of diversity and inclusion literature and an evaluation of methodologies and metrics relating to health research. Available at: https://wellcome.ac.uk/sites/default/files/review-of-diversity-and-inclusion-literature.pdf
Poku EN, Aber A, Phillips P, Essat M, Woods H, Palfreyman S, Kaltenthaler E, Jones G, Michaels J. Systematic review assessing the measurement properties of patient-reported outcomes for venous leg ulcers. British Journal of Surgery
© BMJ Journals |
Sadler S, Tosh J, Pennington R, Rawdin A, Squires H, Romero C, Fischer A, Chilcott J. A cost-effectiveness analysis of condom distribution programmes for the prevention of sexually transmitted infections in England. Journal of Epidemiology and Community Health (2017) 71:897–904. doi:10.1136/jech-2017-209020
Chambers D, Preston L, Salway S, De Saille S, Topakas A, Booth A, Dawson J, Wilsdon JR. The Diversity Dividend: does a more diverse and inclusive research community produce better biomedical and health research? Sheffield: TUOS/Wellcome Trust (2017). Available at: https://wellcome.ac.uk/sites/default/files/the-diversity-dividend-briefing.pdf
Dixon S. Determining the relative cost effectiveness of the fluocinolone acetonide intravitreal implant. Current Medical Research and Opinion (2017) 33:1–2. doi:10.1080/03007995.2017.1366624
© Adis |
Brazier JE, Muston D, Konwea H, Power GS, Barzey V, Lloyd A, Sowade O, Vitti B, Gerlinger C, Roberts. Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies. Investigative Ophthalmology & Visual Science (2017) 58:4818–4825. doi:10.1167/iovs.17-21945
Bermejo I, Stevenson M, Cooper K, Harnan S, Hamilton J, Clowes M, Carroll C, Harrison T, Saha S. Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics (2017) doi:10.1007/s40273-017-0571-8
Bermejo I, Tappenden P, Youn J-H. Response to “Comment on ‘Replicating Health Economic Models: Firm Foundations or a House of Cards?’”. Pharmacoeconomics (2017) doi:10.1007/s40273-017-0574-5